Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by amendison Feb 13, 2015 12:23pm
135 Views
Post# 23427216

First Q result not bad

First Q result not badMBX is strong looking at the result. 1. Revenue up 2. Net profit is $1940 still is not lost. After spending lot of money to pipe lines including Lumisort. Way I understand Management looking to build a comical machine. Also cash flow is positive. They need not to dilute any more to raise money. Two directors warrant gives the needed money. All people buying and selling are not investors. Most are traders. They come to make some money unable they bail out. Today going down not to worry. This is a solid company. most good thing happen to MBX and to the investors bashermasher1 bail out get out from the board. Some one said market moving news not come with the 1Q he got what he hope . I think market moving news come with the AGM march 3 2015 Good luck to longs.
Bullboard Posts